In contrast to chronological ageing, biological ageing refers to the damage to cells over time. Your biological age can be accelerated, leading to age-related diseases. You may think this is an inevitable part of life, but research is showing that that is not necessarily the case.
Can we halt or even reverse chronic biological ageing? Can we improve the human health span, and live longer lives without age-related diseases such as cancer, neurological or cardiovascular diseases?
Find out how some of the world’s leading scientists are tackling these questions, at our upcoming webinar: Unlocking the power of gene expression reprogramming to reverse chronic age-related diseases taking place on Wednesday 24th of May, 3pm BST/ 4pm CET/ 10am EDT
Click here to register your place.
Featuring three expert speakers, you will leave this webinar enlightened on the possibility of targeting the ageing process and unlocking longer, healthier lives for all.
This webinar will cover:
- The latest insights into the Robust Mouse Rejuvenation programme, and implications for late-onset intervention to reverse ageing.
- How to leverage existing datasets to gain a better understanding of age-related disorders and potentially unlock novel targets.
- How the plasma proteome changes with age and is leading to the development of novel therapies, with examples.
– – – – –
Expanding lifespan by reversing age-related disease
Aubrey De Grey, CEO, LEV Foundation
In this presentation, you will learn about the importance of achieving medical control over the ageing process and the reasons why it has not been achieved before. An overview of the Robust Mouse Rejuvenation program will be provided to demonstrate the potential of treating age-related diseases. Additionally, the presentation will discuss the foundation for future research and outline the next steps for the LEV foundation.
How to harness transcriptomics data for ageing-related research
Axel Martinelli, Head of Biology, BigOmics
This presentation will highlight how the Omics Playground Platform can help researchers leverage current bioinformatic approaches and existing databases to not only gain a greater understanding of the mechanisms involved in age-related disorders, but also to identify biomarkers and evaluate the impact of novel therapies. It will demonstrate examples from published studies on topics such as progeria and neurodegenerative disorders.
Molecularizing the science of plasma to target age-related diseases
Salah Mahmoudi, Associate Director, Discovery Research, Alkahest
In this presentation, you will discover how we are leveraging our deep understanding of the plasma proteome and how it changes with age to develop novel therapies for age-related diseases, such as neurological disorders.
You won’t want to miss this, so don’t forget to add this webinar to your calendar. Plus, there will be extended live Q&A with the speakers so come armed with questions!
This webinar has been kindly supported by BigOmics Analytics.
– – – – –